UCAR T-cell Therapy Targeting CD19/ BCMA in Patients With Relapse/ Refractory Autoimmune Diseases
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Clinical Trials Related to Fludarabine
Related studies linked through entity extraction aliases.
A Study to Evaluate Efficacy and Safety of Ciltacabtagene Autoleucel
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of NEUK203-215 Injection in Adult Chinese Patients With Relapsed/Refractory Autoimmune Diseases
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Phase II Study of CD5 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Aggressive T Cell Hematological Malignancies
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
- Status
- RECRUITING
- Phase
- PHASE1
HS-IT101 Injection for Advanced NSCLC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Phase I Study of Preconditioning Radiation Therapy With IL-15 Transduced TGFBR2 KO CAR.TROP2-engineered Cord Blood-derived NK Cells in Patients With Advanced Head and Neck Cancer (RADIANCE-NK)
- Status
- RECRUITING
- Phase
- PHASE1
A Phase 1 Study of ADI-001 in Rheumatoid Arthritis
- Status
- RECRUITING
- Phase
- PHASE1
GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young Adults
- Status
- RECRUITING
- Phase
- PHASE1
Efficacy, Safety, and Pharmacokinetics of ThisCART19A Combined With Olverembatinib in Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- EARLY_PHASE1
Phase I Study of Allogeneic Transforming Growth Factor-beta Receptor Type 2 Knockout CD70 CAR NK Cells in Treatment Refractory Clear Cell Renal Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE1
A Phase 1 Study of FIT-CD19-CAR-T Cells in R/R B-ALL
- Status
- RECRUITING
- Phase
- PHASE1
UPDATE AML: UPdated Disease Monitoring And Treatment for Enhanced Outcomes for Pediatric AML
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
A Phase I Trial Anti-CC Chemokine Receptor 4 Chimeric Antigen Receptor T Cells (CCR4 CAR T Cells) for CCR4 Expressing T-cell Malignancies Including Peripheral T-cell Non-Hodgkin Lymphoma (PTCL) and Cutaneous T-cell Non-Hodgkin Lymphoma (CTCL)
- Status
- RECRUITING
- Phase
- PHASE1
TCRαβ-depleted Progenitor Cell Graft With Early Memory T-cell DLI, Plus Selected Use of Blinatumomab, in naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
Combination Chemotherapy (FLAG-Ida) Followed Immediately by Reduced-Intensity Total Body Radiation Therapy and Donor Hematopoietic Cell Transplant for the Treatment of Adults Age 60 and Older With Newly Diagnosed Adverse-Risk Acute Myeloid Leukemia or Other High-Grade Myeloid Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Efficacy and Safety of Anitocabtagene Autoleucel in Participants With Newly Diagnosed Multiple Myeloma (GEM-AnitoFIRST)
- Status
- RECRUITING
- Phase
- PHASE2
A Study of KITE-363 in Participants With Refractory Autoimmune Diseases
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE1
JWCAR239 in Patients With B Cell Non-Hodgkin Lymphoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
A Study of CC-97540 (BMS-986353 or Zola-cel), CD19-Targeted NEX-T CAR T Cells, in Participants With Active SLE Despite Immunosuppressants (Breakfree-SLE)
- Status
- RECRUITING
- Phase
- PHASE2